AbbVie Inc. | Mutual Funds

Mutual Funds that own AbbVie Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
American Funds Investment Company of America
57,880,449
3.82%
0
6.05%
06/30/2018
Vanguard Total Stock Market Index Fund
38,089,751
2.52%
155,184
0.49%
07/31/2018
American Funds Capital Income Builder
30,893,000
2.04%
0
3.1%
06/30/2018
American Funds Capital World Growth & Income Fund
29,611,073
1.96%
300,000
3.18%
06/30/2018
Vanguard 500 Index Fund
27,443,605
1.81%
28,988
0.59%
07/31/2018
American Funds Growth Fund of America
23,553,441
1.56%
1,016,971
1.24%
06/30/2018
American Funds AMCAP Fund
18,121,000
1.2%
0
2.77%
06/30/2018
SPDR S&P 500 ETF
16,762,500
1.11%
193,347
0.59%
09/06/2018
American Funds American Mutual Fund
16,465,700
1.09%
0
3.27%
06/30/2018
Vanguard Institutional Index Fund
14,661,598
0.97%
17,072
0.59%
07/31/2018

About AbbVie

View Profile
Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.